Is MRD Already a Surrogate for Survival?
In this stimulating session, Andriano Venditti, MD, Roland Walter, MD, PhD, and Farhad Ravandi, MD, present talks on the hot topic of utilizing MRD in clinical practice. E-learning webcasts include MRD as a therapy-dependent prognostic factor, treatment algorithms and whether MRD is indeed a surrogate for survival.
Presentations
University of Rome Tor Vergata, Rome, Italy
Adriano Venditti, MD, from the University of Rome Tor Vergata, Rome, Italy, discusses the potential of MRD as a therapy-dependent prognostic factor.
Fred Hutchinson Cancer Research Center, Seattle, WA
Roland Walter, MD, PhD, Fred Hutchinson Cancer Research Center, Seattle, WA, gives a presentation on treatment algorithms based on MRD testing.
University of Texas MD Anderson Cancer Center, Houston, TX
In his talk, Farhad Ravandi, MD, University of Texas MD Anderson Cancer Center, Houston, TX, explores a key question: is MRD already a surrogate for survival?
